The Indian Council of Medical Research (ICMR) released two significant studies addressing child diarrhoea prevalence and COVID-19 virus mutations in India. The studies provide data on disease patterns and viral evolution affecting public health strategies.
Child Diarrhoea Prevalence Study
ICMR’s multi-centre study assessed diarrhoeal disease incidence among children under five years across various Indian states. Data showed that 12% of surveyed children experienced diarrhoea in the preceding two weeks. The study identified rotavirus as the leading pathogen in 40% of cases. Regions with poor sanitation reported higher incidence rates. The research included over 10,000 children from urban and rural settings.
COVID-19 Mutation Analysis
ICMR analysed SARS-CoV-2 genome sequences collected between 2020 and 2023. The study identified over 50 significant mutations, with the Delta and Omicron variants showing high transmissibility. A novel mutation in the spike protein was detected in samples from Maharashtra and Kerala. The research involved sequencing 5,000 viral genomes from patients across 15 states. Findings indicated mutation-driven changes in virus infectivity and vaccine response.
Implications for Public Health Policy
The child diarrhoea study supports targeted vaccination and sanitation improvement programmes. Rotavirus vaccination coverage was noted to be below 60% in high-incidence areas. The mutation study informs vaccine update strategies and diagnostic test adjustments. ICMR recommended continuous genomic surveillance to monitor emerging variants and guide treatment protocols.
Research Methodology and Collaborations
Both studies employed cross-sectional and longitudinal data collection methods. The diarrhoea study used stool sample analysis and clinical assessments. The COVID-19 mutation study utilised next-generation sequencing technology. Collaborating institutions included AIIMS, National Institute of Virology, and regional medical colleges. Data collection spanned urban and rural healthcare centres.
What to Study for UPSC Exams?
- Vaccine Development Processes
- Genomic Surveillance Mechanisms
- Waterborne Disease Control
- Virus Mutation and Epidemiology
Vaccine Development Processes
Vaccines undergo preclinical and multiple clinical trial phases before approval. mRNA vaccines use lipid nanoparticles for delivery of genetic instructions. Adjuvants enhance immune response by activating innate immunity. Cold chain logistics maintain vaccine efficacy during transport. Reverse vaccinology employs genomic data to identify antigen targets.
Genomic Surveillance Mechanisms
Genomic surveillance tracks pathogen mutations via sequencing technologies like NGS. It enables early detection of variants and informs public health responses. Data is shared globally through platforms like GISAID. Wastewater sampling provides community-level viral load insights. Bioinformatics pipelines analyze sequence data for mutation patterns.
Waterborne Disease Control
Waterborne diseases spread through contaminated water containing pathogens like Vibrio cholerae and Giardia. Chlorination and filtration are primary water treatment methods. Sanitation infrastructure reduces fecal-oral transmission. Surveillance includes monitoring water quality and outbreak reporting. Vaccines exist for diseases like cholera and typhoid.
Virus Mutation and Epidemiology
Virus mutations arise from replication errors and selective pressures. Spike protein mutations can alter infectivity and immune escape. Epidemiology studies transmission patterns, reproduction number, and outbreak dynamics. Variant classification includes VOC (Variants of Concern) and VOI (Variants of Interest). Mutation rates vary among RNA viruses.
Last Modified: April 13, 2026